Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

10 companies warned for making ‘fraudulent claims’ about diabetes supplements | Efpeglenatide & CVD

News You Need to Know Today
10 companies warned for making ‘fraudulent claims’ about diabetes supplements | Efpeglenatide & CVD
Friday, September 10, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA, FTC warn 10 companies for making ‘fraudulent claims’ about unapproved diabetes supplements

Each company is believed to be in violation of the Federal Food, Drug and Cosmetic Act. They have 15 working days to respond. 

READ MORE >
pills-384846_960_720.jpg
Share on Twitter Share on Facebook Share on Linkedin

FDA, FTC warn 10 companies for making ‘fraudulent claims’ about unapproved diabetes supplements

Share on Twitter Share on Facebook Share on Linkedin
pills-384846_960_720.jpg
Each company is believed to be in violation of the Federal Food, Drug and Cosmetic Act. They have 15 working days to respond. 
READ MORE >

Efpeglenatide lowers risk of CVD in patients with type 2 diabetes

The medication was also associated with a reduced number of renal events. 

READ MORE >
Patient
Share on Twitter Share on Facebook Share on Linkedin

Efpeglenatide lowers risk of CVD in patients with type 2 diabetes

Share on Twitter Share on Facebook Share on Linkedin
Patient
The medication was also associated with a reduced number of renal events. 
READ MORE >

Women in cardiology receive less money from CMS, submit fewer charges

More research is still needed to find out why these differences exist, but the authors did offer some possible explanations. 

READ MORE >
women doctors
Share on Twitter Share on Facebook Share on Linkedin

Women in cardiology receive less money from CMS, submit fewer charges

Share on Twitter Share on Facebook Share on Linkedin
women doctors
More research is still needed to find out why these differences exist, but the authors did offer some possible explanations. 
READ MORE >

Aortic valve replacement on the rise among patients with Alzheimer’s disease, related dementias

The increasing popularity of TAVR appears to be the biggest reason for this shift.

READ MORE >
Treating elderly atrial fibrillation (AFib) patients—even those who are traditionally ineligible for direct oral anticoagulants (DOACs)—with a very low dose of edoxaban is associated with improved outcomes, according to new research published in JAMA Network Open.
Share on Twitter Share on Facebook Share on Linkedin

Aortic valve replacement on the rise among patients with Alzheimer’s disease, related dementias

Share on Twitter Share on Facebook Share on Linkedin
Treating elderly atrial fibrillation (AFib) patients—even those who are traditionally ineligible for direct oral anticoagulants (DOACs)—with a very low dose of edoxaban is associated with improved outcomes, according to new research published in JAMA Network Open.
The increasing popularity of TAVR appears to be the biggest reason for this shift.
READ MORE >

Featured Articles

Revealed: Why severe COVID-19 infections are more common in people with diabetes

Specialists at the University of Michigan hope their findings can help patients receive an effective treatment early on in their infection. 

READ MORE >
Patient doctor with masks. A team of specialists from Cleveland Clinic reviewed nearly 3,000 medications, writing that a common type 2 diabetes medication offered the most potential as an effective treatment for AFib. 
Share on Twitter Share on Facebook Share on Linkedin

Revealed: Why severe COVID-19 infections are more common in people with diabetes

Share on Twitter Share on Facebook Share on Linkedin
Patient doctor with masks. A team of specialists from Cleveland Clinic reviewed nearly 3,000 medications, writing that a common type 2 diabetes medication offered the most potential as an effective treatment for AFib. 
Specialists at the University of Michigan hope their findings can help patients receive an effective treatment early on in their infection. 
READ MORE >

Heart attacks more common among young adults who use marijuana—but a key question remains

Researchers tracked data from more than 33,000 adults under the age of 45.

READ MORE >
Marijuana use among older adults is associated with a heightened risk of atrial and ventricular arrhythmias, according to new research published in the American Journal of Cardiology. “Marijuana use increases sympathetic nervous system activity and inhibits cardiac parasympathetic innervation, resulting in elevated heart rate, elevated blood pressure, and an increase in myocardial oxygen demand.
Share on Twitter Share on Facebook Share on Linkedin

Heart attacks more common among young adults who use marijuana—but a key question remains

Share on Twitter Share on Facebook Share on Linkedin
Marijuana use among older adults is associated with a heightened risk of atrial and ventricular arrhythmias, according to new research published in the American Journal of Cardiology. “Marijuana use increases sympathetic nervous system activity and inhibits cardiac parasympathetic innervation, resulting in elevated heart rate, elevated blood pressure, and an increase in myocardial oxygen demand.
Researchers tracked data from more than 33,000 adults under the age of 45.
READ MORE >

FDA approves new solution for preserving hearts before transplantation

The system preserves hearts that can’t be procured or transplanted right away due to a limited availability of storage space.

READ MORE >
approved approval
Share on Twitter Share on Facebook Share on Linkedin

FDA approves new solution for preserving hearts before transplantation

Share on Twitter Share on Facebook Share on Linkedin
approved approval
The system preserves hearts that can’t be procured or transplanted right away due to a limited availability of storage space.
READ MORE >

Valve-in-valve TMVR an effective option for patients with mitral prosthesis dysfunction

Adjusted mortality and perioperative complications were both lower among patients undergoing ViV TMVR.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Valve-in-valve TMVR an effective option for patients with mitral prosthesis dysfunction

Share on Twitter Share on Facebook Share on Linkedin
Adjusted mortality and perioperative complications were both lower among patients undergoing ViV TMVR.
READ MORE >

People living with HIV face a heightened risk of sudden cardiac death

The risk was especially high in patients with high viral loads of HIV.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

People living with HIV face a heightened risk of sudden cardiac death

Share on Twitter Share on Facebook Share on Linkedin
The risk was especially high in patients with high viral loads of HIV.
READ MORE >

In Case You Missed It

Examining the Use of Prostacyclin Pathway Agents When Treating Patients with PAH

Pulmonary arterial hypertension (PAH) is a rare, life-threatening disease with no known cure.

READ MORE >
iStock-1294678839.jpg
Share on Twitter Share on Facebook Share on Linkedin

Examining the Use of Prostacyclin Pathway Agents When Treating Patients with PAH

Share on Twitter Share on Facebook Share on Linkedin
iStock-1294678839.jpg
Pulmonary arterial hypertension (PAH) is a rare, life-threatening disease with no known cure.
READ MORE >

In Other News

Another radiology group requiring vaccination against COVID-19 to attend its conference

The Radiology Business Management Association is asking all 2021 PaRADigm attendees to provide proof of inoculation prior to arriving in Las Vegas next month. 

READ MORE >
vaccine syringe covid-19 coronavirus
Share on Twitter Share on Facebook Share on Linkedin

Another radiology group requiring vaccination against COVID-19 to attend its conference

Share on Twitter Share on Facebook Share on Linkedin
vaccine syringe covid-19 coronavirus
The Radiology Business Management Association is asking all 2021 PaRADigm attendees to provide proof of inoculation prior to arriving in Las Vegas next month. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Is TAVR too common among younger patients? | New-look heart failure device delivers | SCAI to study women in the cath lab
Cardiologist compensation keeps climbing | Investing in robotic tech | Doc agrees to pay $6.7M | Virtual nurses
ASNC speaks to policymakers | New IVL tech impresses | FDA clears high-pressure balloon catheter | RSNA names a new editor
Pacemakers recalled again | Johnson & Johnson makes a move | GLP-1 drugs & AFib | Strokes after PFA | New LAAO data
More recalls announced due to high-risk device | AATS helps surgeons manage a major complication | How guidelines impact care
Week in Review: TAVR or SAVR? | Key trends in cardiac CT | Fraud allegations lead to $6.7M settlement | CTO PCI
FDA clears intravascular imaging tech | Key trends in cardiac CT | Heartflow sues rival | Opportunistic screening

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …5
    • Page 6
    • Page 7
    • Page 8
    • Current page 9
    • Page 10
    • Page 11
    • Page 12
    • Page 13 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme